ImmunityBio, Inc. earnings per share and revenue

IBRX earnings per share for the last quarter are -0.14 USD whereas the estimation was -0.18 USD which accounts for 21.36% surprise. Company revenue for the same period amounts to 6.11 M USD despite the estimated figure of 2.92 M USD. Estimated earnings per share for the next quarter are -0.22 USD, and revenue is expected to reach 5.85 M USD. Also watch annual changes over time to get a bigger picture of IBRX earnings per share and revenue dynamics.